The FDA’s Oncologic Drugs Advisory Committee (ODAC) on Thursday voted 6 to 3 that AstraZeneca has not demonstrated its oral ...

Baron Capital, an investment management company, released its Q1 2026 investor letter for the “Baron Health Care Fund”. A ...

The advisory panel wasn't convinced that a clinical trial proved that early switching to camizestrant improved long-term ...

Sir Kier Starmer announces the multi-million-pound investment in the House of Commons.

AstraZeneca has paid $25 million to pick up a preclinical EGFR degrader that was at the center of its existing pact with ...

The FDA’s real-time clinical trial mechanism allows drug sponsors to transmit data immediately to the regulator through the ...

By Pushkala Aripaka and Maggie Fick April 29 (Reuters) - AstraZeneca beat first-quarter profit expectations and maintained ...

The FDA is looking at a slew of label expansions this month, including one that could open up home-based treatments for Alzheimer’s disease.

As AstraZeneca braces for the impact of the U.S. “most favored nation” drug pricing policy, CEO Pascal Soriot suggests that a ...

Our AstraZeneca (NASDAQ:AZN) call comes one day after the British drugmaker reported Q1 2026 revenue of $15.29 billion, up 13 ...

AstraZeneca reported rises in revenue and core earnings for the first quarter, saying growing sales of its cancer and ...

LONDON, April 29 (Reuters) - Prime Minister Keir Starmer said on Wednesday that Britain's biggest company AstraZeneca would ...